144 related articles for article (PubMed ID: 33741867)
1. Rate of incidental central nervous system meningioma detected in patients undergoing 18F-fluciclovine PET/CT imaging for evaluation of prostate cancer.
Baiomy A; Schellingerhout D; Chapin BF; Weinberg JS; Raza SM; Macapinlac H; Ravizzini G
Nucl Med Commun; 2021 Jul; 42(7):755-762. PubMed ID: 33741867
[TBL] [Abstract][Full Text] [Related]
2. Detection of Additional Primary Neoplasms on
Parihar AS; Schmidt LR; Dehdashti F; Wahl RL
J Nucl Med; 2022 May; 63(5):713-719. PubMed ID: 34413144
[TBL] [Abstract][Full Text] [Related]
3. Incidental Spinal Meningioma on an 18F-Fluciclovine PET/CT.
Marcus C; Baugnon K; Schuster DM
Clin Nucl Med; 2022 Mar; 47(3):e313-e314. PubMed ID: 35025777
[TBL] [Abstract][Full Text] [Related]
4. Initial Institutional Experience with 18F-Fluciclovine PET-CT in Biochemical Recurrence of Prostate Cancer.
Farkas AB; Green ED; Thaggard AL; Vijayakumar V; Henegan JC; Lirette ST; Nittala MR; Vijayakumar S
South Med J; 2021 Nov; 114(11):703-707. PubMed ID: 34729614
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 18F-Fluciclovine PET/CT and 99mTc-MDP bone scan in detection of bone metastasis in prostate cancer.
Chen B; Wei P; Macapinlac HA; Lu Y
Nucl Med Commun; 2019 Sep; 40(9):940-946. PubMed ID: 31343613
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of 18F-fluciclovine PET/CT for regional lymph node metastases in patients with primary prostate cancer: a multicenter phase II clinical trial.
Suzuki H; Jinnouchi S; Kaji Y; Kishida T; Kinoshita H; Yamaguchi S; Tobe T; Okamura T; Kawakita M; Furukawa J; Otaka A; Kakehi Y
Jpn J Clin Oncol; 2019 Sep; 49(9):803-811. PubMed ID: 31095314
[TBL] [Abstract][Full Text] [Related]
8. Multifocal Meningiomas Mimicking Dural-Based Intracranial Metastases at 18F-Fluciclovine PET/CT.
Manganaro MS; Millet JD; Manganaro MS
Clin Nucl Med; 2019 Jul; 44(7):594-595. PubMed ID: 31107759
[TBL] [Abstract][Full Text] [Related]
9. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers.
Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C
J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Utility of
Nakamoto R; Harrison C; Song H; Guja KE; Hatami N; Nguyen J; Moradi F; Franc BL; Aparici CM; Davidzon G; Iagaru A
Mol Imaging Biol; 2021 Aug; 23(4):614-623. PubMed ID: 33469884
[TBL] [Abstract][Full Text] [Related]
11. Fluciclovine, Anti-1-Amino-3-[
Nguyen QD; Amato R; Riascos R; Ballester L; Tandon N; Blanco A; Esquenazi Y
World Neurosurg; 2018 Nov; 119():132-136. PubMed ID: 30077749
[TBL] [Abstract][Full Text] [Related]
12. Incidental 18F-Fluciclovine Uptake in a Desmoid Tumor Detected in a Patient Undergoing PET/CT Imaging for Prostate Cancer.
Baiomy A; Jensen CT; Ward JF; Chasen BA; Ravizzini GC
Clin Nucl Med; 2021 Apr; 46(4):355-357. PubMed ID: 33323736
[TBL] [Abstract][Full Text] [Related]
13. 18F-Fluciclovine PET/CT in Therapeutic Decision Making for Prostate Cancer: A Large Single-Center Practice-Based Analysis.
Dreyfuss AD; Ahn GS; Barsky AR; Gillman JA; Vapiwala N; Pantel AR
Clin Nucl Med; 2021 Mar; 46(3):187-194. PubMed ID: 33315672
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of 18F-fluciclovine PET/CT in primary lymph node staging of prostate cancer.
Hoekstra RJ; Beulens A; Vrijhof EHJEJ; Wyndaele DNJ; Roef M; Brouwer LJM; Somford DM; Sedelaar M; van Basten JA
Nucl Med Commun; 2021 May; 42(5):476-481. PubMed ID: 33323869
[TBL] [Abstract][Full Text] [Related]
15. 18F-Fluciclovine PET/CT: A Potential Imaging Biomarker for the Evaluation of Multiple Myeloma.
Marcus C; Schuster DM; Tajmir SH
Clin Nucl Med; 2022 Sep; 47(9):e613-e615. PubMed ID: 35930716
[TBL] [Abstract][Full Text] [Related]
16. Recurrent Malignant Melanoma Detected on 18F-Fluciclovine PET/CT Imaging for Prostate Cancer.
Teoh EJ; Tsakok MT; Bradley KM; Hyde K; Subesinghe M; Gleeson FV
Clin Nucl Med; 2017 Oct; 42(10):803-804. PubMed ID: 28806256
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for
Kim EH; Siegel BA; Teoh EJ; Andriole GL;
Urol Oncol; 2021 Jun; 39(6):365.e9-365.e16. PubMed ID: 33160848
[TBL] [Abstract][Full Text] [Related]
18. Incidental Detection of Urothelial Carcinoma on 18F-Fluciclovine PET/CT.
Surasi DSS; Lu Y; Corn P; Pettaway C; Bathala T
Clin Nucl Med; 2021 Feb; 46(2):e114-e115. PubMed ID: 33156041
[TBL] [Abstract][Full Text] [Related]
19. Effect of Androgen Deprivation Therapy on the Results of PET/CT with 18F-Fluciclovine in Patients with Metastatic Prostate Cancer.
Bach-Gansmo T; Korsan K; Bogsrud TV
Tomography; 2022 Jun; 8(3):1477-1484. PubMed ID: 35736868
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Diagnostic Utility of Fluciclovine PET/CT Versus Pelvic Multiparametric MRI for Prostate Cancer in the Pelvis in the Setting of Rising PSA After Initial Treatment.
Chen B; Bathala TK; Xu G; Teyateeti A; Chapin BF; Tang C; Tu SM; Macapinlac HA; Lu Y
Clin Nucl Med; 2020 May; 45(5):349-355. PubMed ID: 31977495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]